Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Utah Launches Campaign to Fight Opioid Abuse, Overdoses

By AP | May 1, 2017

SALT LAKE CITY (AP) — Utah pharmacists will start putting red stickers on bottles of opioids that warn patients about the risk of overdose and addiction as part of a new awareness campaign to combat painkiller abuses and deaths.

The Utah Department of Health’s monthlong campaign kicks off Monday and is meant to encourage dialogue between pharmacists and patients about opioid risks.

The rate of prescription opioids dispensed in Utah grew 30 percent from 2002 to 2015, statistics from the department show. Nearly 300 Utah residents died of opioid overdoses in 2015, according to the latest data available from the department.

“Given the high number of deaths associated with prescription opioids, understanding the risks of opioids is vital to patient safety.” said Angela Dunn, deputy state epidemiologist for the health department.

The new initiative is a collaborative effort by the health department, the Utah Pharmacy Association and the Utah Department of Commerce.

The red stickers — which read “Caution: Opioid. Risk of Overdose and Addiction” — will prompt patients to ask pharmacists questions about their potentially addictive medications, said Greg Jones, chairman of the Utah Pharmacy Licensing Board.

“People underestimate the danger of their medications,” Jones said. “People think they’ll be fine taking it, and quite often they’re not.”

Pharmacists can discuss with patients proper use, storage and disposal of opioids and provide naloxone, an overdose-reversing drug.

The red-sticker campaign is just one of several initiatives the Utah Department of Health has been working on in recent years to reduce opioid overdoses and increase public awareness about the issue.

“It will take some time to see results,” Dunn said. “But anecdotally, patients are becoming more educated on what an opioid is and the dangers it can possess.”

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!

Related Articles Read More >

This is the logo of Novartis.
Novartis breaks ground on North Carolina facility
AstraZeneca
AstraZeneca to invest $2B in Maryland, support 2,600 jobs
This is the logo of Novartis.
Novartis opens new manufacturing plant in California
samsung biologics (1)
Samsung Biologics completes Bioepis spinoff to become pure-play pharma CDMO
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE